Castle Biosciences Inc (CSTL)
29.35
+0.93
(+3.27%)
USD |
NASDAQ |
Oct 04, 16:00
29.30
-0.06
(-0.19%)
After-Hours: 20:00
Castle Biosciences Shareholders Equity (Annual): 391.27M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 391.27M |
| December 31, 2022 | 399.15M |
| December 31, 2021 | 411.74M |
| December 31, 2020 | 415.69M |
| Date | Value |
|---|---|
| December 31, 2019 | 85.11M |
| December 31, 2018 | -10.07M |
| December 31, 2017 | -14.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
85.11M
Minimum
2019
415.69M
Maximum
2020
340.59M
Average
399.15M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Danaher Corp | 53.49B |
| Exact Sciences Corp | 3.145B |
| Illumina Inc | 5.745B |
| Mettler-Toledo International Inc | -149.94M |
| Natera Inc | 765.33M |